Heme oxygenase-1 (HO-1) is induced by a variety of conditions associated with oxidative stress. We demonstrated that mildly oxidized LDL markedly induces HO-1 in human aortic endothelial and smooth muscle cell cocultures and that its induction results in the attenuation of monocyte chemotaxis resulting from treatment with mildly oxidized LDL in vitro. To elucidate the role of HO-1 in the development of atherosclerotic lesions in vivo, we modulated HO-1 expression in LDL-receptor knockout mice fed high-fat diets. During 6-week high-fat diet trials, intraperitoneal injections of hemin (H group) or hemin and desferrioxamine (HD group) to induce HO-1, Sn-protoporphyrin IX to inhibit HO-1 (Sn group), and saline as control (C group) were performed. Both the H and HD groups showed significantly less mean atherosclerotic lesions in the proximal aorta compared with the C group, whereas the Sn group showed larger lesion compared with the C group. Modulation of HO expression and HO activities were confirmed by Northern blot analysis and HO activity assay. Immunohistochemical studies revealed significant HO-1 expression in atherosclerotic lesions, where oxidized phospholipids also localized. Major cell types expressing HO-1 were macrophages and foam cells in the lesions. HO modulations affected plasma lipid hydroperoxide (LPO) levels and nitrite/nitrate levels. These results suggest that HO-1, induced under hyperlipidemia, functioned as an intrinsic protective factor against atherosclerotic lesion formation, possibly by inhibiting lipid peroxidation and influencing the nitric oxide pathway. (Circ Res. 2001;88:506-512.) Key Words: heme oxygenase Ⅲ LDL-receptor knockout mice Ⅲ high-fat diet Ⅲ oxidized LDL Ⅲ atherosclerosis Original
M icrosomal heme oxygenase (HO) catalyzes the initial and rate-limiting reaction in heme catabolism. 1, 2 Using NADPH-cytochrome P450 reductase as an electron donor, HO oxidatively cleaves the ␣-meso carbon bridge of its substrate heme to yield equimolar quantities of biliverdin, carbon monoxide (CO), and free iron. 3 In addition to its function in heme degradation and iron reutilization, 1, 4 recent studies suggest a potential protective function of this enzyme against oxidative stress, 5-9 the regulation of cell growth and differentiation, 10, 11 and vascular tone. 12, 13 The antioxidant activity of HO derives not only from the elimination of prooxidant heme but also from the biological activities of its reaction products, biliverdin and bilirubin. Biliverdin and its metabolite by biliverdin reductase, bilirubin, are powerful antioxidants capable of inhibiting the oxidation of LDL. 14, 15 Free iron inhibits the de novo synthesis of heme by modulating the activity of ␦-aminolevulinate synthase 16 and induces ferritin through an iron-responsive element. 17 The induction of ferritin has been shown to have cytoprotective effects against oxidative injuries by heme, hydrogen perox-ides, osmotic stress, and ultraviolet irradiation. 18 -20 CO binds to soluble guanylate cyclase as a heme ligand, modulating its activity and resulting in an intracellular cGMP increase similar to that attributable to nitric oxide (NO), although a different signaling pathway may be involved. 21, 22 In addition, the anti-inflammatory effect of CO through the mitogenactivated protein kinase pathway has been reported recently. 23 In this respect, CO has been suggested as a possible gaseous messenger in both the nervous system 24 and the cardiovascular system. 7, 25 Accumulating evidence suggests that oxidized LDL (ox-LDL) plays an important role during the early phases of atherogenesis via its proinflammatory properties. 26 -29 HO-1 is remarkably induced by mildly oxLDL in endothelial cells, smooth muscle cells, and macrophages. 30 -32 HO-1 expression is also highly responsive to oxidized PAPC, a bioactive oxidized phospholipid existing in LDL. 30 In addition, we found that HO-1 inhibits oxLDL-dependent monocyte chemotaxis through its products, bilirubin and biliverdin, using artery wall cocultures. 30 These findings prompted us to examine whether HO-1 inhibits the progression of atherosclerosis in vivo.
In the present study, we modulated HO activity in LDLreceptor knockout mice and examined the effect on lesion development under 2 different kinds of high-fat diets. Mice treated with the HO inhibitor exhibited enhanced atherosclerotic lesion formation compared with control animals. Opposing results were observed when mice were treated with the HO-1 inducer. The antiatherogenic properties of HO-1 seem to be through inhibition of lipid peroxidation and influences on the NO pathway. These data suggest the possibility that HO-1 influences atherosclerotic lesion formation and development as an intrinsic antioxidant system.
Materials and Methods

Animal Handling and Procedures
LDL-receptor knockout mice 33 were fed 2 different high-fat diets to evaluate the function of HO in atherogenesis. The high-cholesterol diet contained 15% fat, 1.25% cholesterol, and 0.5% cholic acid, and the Western diet 34 contained 21% fat and 0.15% cholesterol. Animals were challenged with these diets at 10 weeks of age, and feeding continued for 6 weeks. During high-fat diet trials, intraperitoneal injections of hemin (25 mg/kg body weight) (H group, nϭ10) or hemin and desferrioxamine (10 mg/kg body weight) (HD group, nϭ12) to induce HO-1 and Sn-protoporphyrin IX (7.5 mg/kg body weight) (Sn group, nϭ12) to inhibit HO-1 or saline (C group, nϭ12) as control were performed 4 times per week.
Atherosclerotic Lesion Analysis, Immunohistochemistry, and Immunofluorescence
Atherosclerotic lesion area was calculated using serial sections of the first 400 m of the ascending aorta, as previously described. 35 An avidin-biotinylated peroxidase 35 or double-fluorescent 36 system was used for immunohistochemical analyses. The following primary antibodies were used: polyclonal rabbit anti-rat HO-1 (StressGen), monoclonal rat anti-mouse F4/80 antigen (Serotec), monoclonal mouse antioxidized phospholipids, 37, 38 or monoclonal mouse antihuman smooth muscle actin (Dako). For colocalization studies of HO-1 staining, fluorescein isothiocyanate-conjugated anti-mouse IgG against antioxidized phospholipids antibody and tetramethylrhodamine isothiocyanate-conjugated anti-rabbit IgG against anti-HO-1 antibody were used. Double immunofluorescence photomicroscopy was performed with an Olympus Provis AX80 microscope.
HO Assay
Aortas in the same group were homogenized and centrifuged, and microsomal fractions were resuspended in 100 mmol/L of potassium phosphate buffer (pH 7.4) containing 2 mmol/L MgCl 2 . HO activities were measured by determining the level of bilirubin formation, as previously described. 20, 39 The protein content was determined by the method described by Lowry et al. 40 
Hematocrit, Plasma Lipoprotein, and Lipid Hydroperoxides
Blood was collected from the retro-orbital plexus of mice fasted overnight using heparin-coated capillaries. The hematocrit was determined by the use of capillary microhematocrit technique. Plasma cholesterol and triglyceride concentrations were determined enzymatically, as described previously. 41 Plasma lipid hydroperoxide (LPO) levels were measured by the method of Yagi et al. 42 
RNA Extraction and Northern Blot Analysis
Total RNA was isolated by Trizol reagent (GIBCO BRL) from aortic tissue after high-fat diet for 3 weeks in each group. Total RNA (15 g) was electrophoresed in a formaldehyde/1% agarose gel and then transferred to nylon membrane and cross-linked by ultraviolet irradiation. The blots were prehybridized, hybridized with 32 Plabeled rat HO-1 cDNA, washed, and exposed to Hyperfilm-ECL (Amersham Pharmacia), as previously described. 30 Densitometric analysis of HO-1 mRNA expression was performed and standardized with ␤-actin RNA.
Plasma Nitrite and Nitrate Measurement
Plasma nitrite and nitrate, referred as NOx, were separated and quantitated with HPLC-Griess system (EICOM). 43, 44 Plasma was 
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Heme Oxygenase-1 as an Antiatherogenic Molecule mixed with methanol (vol/vol; 1:1) and centrifuged to remove lipoproteins, and 10 L of the supernatant was used for the assay. Every sample was measured in duplicate.
Data Analysis
All values are expressed as meanϮSD. Differences were evaluated for significance by one-way ANOVA analysis. An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results
HO-1 Expression in the Atherosclerotic Lesions of LDL-Receptor Knockout Mice
To elucidate the role of HO-1 in the development of atherosclerosis in vivo, we examined by immunohistochemistry HO-1 expression in LDL-receptor knockout mice 33 fed high-fat diets. 
Effect of HO-1 Modulation on Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice Fed High-Fat Diets
On the basis that atherosclerotic lesions in LDL-receptor knockout mice expressed HO-1, we modulated HO activity in the mice fed a high-fat diet to examine the role of HO on the development of atherosclerotic lesions. Two different highfat diets containing different amounts of cholesterol and resulting in more or less extreme hypercholesteremia were used to examine different stages of atherosclerotic lesion formation. HO-1 induction was performed by hemin (H group) or hemin and desferrioxamine (HD group), and HO inhibition was performed by SnPP IX (Sn group). Hemin is a potent transcriptional inducer of HO-1, and hemin has been shown to augment HO-1 induction by oxLDL. 30 In one group, we coadministered desferrioxamine with hemin, because the addition of desferrioxamine reduced monocyte chemotaxis induced by oxLDL in our previous experiments. 30 SnPP IX is widely used as a competitive inhibitor of HO. 9, 13, 20, 30 Figure 3A represents the comparison of atherosclerotic lesion formation in the ascending aorta after the Western diet. The Sn group resulted in a significant increase in mean lesion size (m 2 /section) compared with the C group (PϽ0.001), whereas the H and HD groups resulted in decreases compared with the C group (PϽ0.05 and PϽ0.01, respectively). Figure  3B shows the comparison of atherosclerotic lesion formation after the high-cholesterol diet. With this diet, mice developed around 10-times larger lesions compared with the Western diet. Nevertheless, similar effects on lesion development were observed by HO modulation.
To examine whether HO-1 is modulated in the pharmacological treatments, Northern blot analysis and HO activity assay were performed with aortic tissues. Elevated HO-1 mRNA expressions in the aorta were confirmed by the H and HD groups compared with the C groups after 3-week Western and high-cholesterol diets (Figure 4) . These results suggest that hemin administration augmented HO-1 induction during high-fat diets. HO activities in aortic tissues after the high-fat diets are shown in the Table. Significant modulation of HO activities was confirmed after the 2 different diets.
Effects of HO Modulation on Plasma LPO Levels and NO Pathway
To elucidate how HO modulation resulted in antiatherogenic effect, we examined body weight, plasma total cholesterol, triglycerides, and HDL levels (data not shown). However, these parameters were not affected by HO modulation, suggesting that antiatherogenic properties of HO may not be conducted through the direct changes of plasma lipid profiles. Next, we examined plasma LPO levels by hemoglobin methylene blue method ( Figure 5 ), because biliverdin and bilirubin, products of HO pathway, have been reported to inhibit lipid peroxidation in vitro. 14 The high-cholesterol diet resulted in higher LPO levels compared with the Western diet. Mice in the Sn group exhibited increased levels of plasma LPO levels, and an opposing effect was observed in the H and HD groups. These changes were consistent with the two different high-fat diets used. Coadministration of desferrioxamine with hemin seems to have limited additional effect on preventing lipid peroxidation. These results suggest that the antiatherogenic effect of HO may be mediated, in part, through the inhibition of lipid peroxidation.
Impaired NO synthesis and availability are suggested in the atherosclerotic arteries under hypercholesteremic conditions. 45 To examine the effect of HO modulation on NO pathway, we measured NOx concentration by the HPLC-Griess method. 43, 44 Plasma NOx levels were significantly decreased after high-fat diets compared with the chow diet ( Figure 6A ). Greater decrease in plasma NOx was obtained after the high-cholesterol diet compared with the Western diet. Interestingly, mice in the H and HD groups preserved higher NOx levels compared with the C group after the Western diet ( Figure 6B ) and the high-cholesterol diet (Fig-Figure 3 . Effect of HO modulation on the development of aortic atherosclerotic lesions after feeding of a Western diet (A) or high-cholesterol diet (B) to LDL-receptor knockout mice. Mice were treated by intraperitoneal injections of saline (C), hemin (H), hemin and desferrioxamine (HD), or Sn-protoporphyrin IX (Sn) during 6-week feeding of the high-fat diets. Atherosclerotic lesion areas were determined using serial sections of the first 400 m of the ascending aorta. Data represents meanϮSD. *PϽ0.05; **PϽ0.01; ***PϽ0.001. 1 through 4) or high-cholesterol diet (lanes 5 through 8) feeding. Total RNA (15 g) from mice in the same group was prepared, and Northern blot analysis was performed. Mice were treated with saline (lanes 1 and 5), hemin (lanes 2 and 6), hemin and desferrioxamine (lanes 3 and 7) , or SnPP IX (lanes 4 and 8) .
ure 6C), whereas mice in the Sn group showed decreased levels.
Discussion
In the present study, we examined the possible role of HO-1 in atherogenesis using LDL-receptor knockout mice fed a high-fat diet. As judged by immunohistochemistry and Northern blot analysis, HO-1 was expressed in the atherosclerotic lesions and was mainly localized in the macrophages in this model. Mice treated with SnPP IX had enhanced atherosclerotic lesion formation, whereas animals treated with hemin or hemin with desferrioxamine had smaller lesions compared with control animals.
HO-1 was not expressed in normal arteries of LDLreceptor knockout mice (data not shown) and was only expressed in atherosclerotic arteries. Previous in vitro studies showed that HO-1 was scarcely expressed in cultured macrophages, vascular endothelial cells, and smooth muscle cells without any stimuli or was expressed in these cells when exposed to native LDL and that HO-1 was remarkably induced by oxidized lipids, including oxLDL, oxidized PAPC, and bioactive phospholipid components. 30, 31, 46 These results may suggest that a proinflammatory hyperlipidemic environment rich in oxidized lipids induced HO-1 in this murine model. This idea may be supported by the results of immunohistochemical and double-immunofluorescent analyses showing that a majority of HO-1-expressing cells were colocalized with oxidized phospholipids (Figures 1 and 2) . Recently, we also observed similar results in human atherosclerotic lesions in directional coronary atherectomy specimens (K. Ishikawa, unpublished data, February 2001) .
In this study, we also tried to explore the mechanisms against atherosclerotic lesion formation through HO-1. Stocker et al 14 have reported a significant role of bilirubin, the product of HO pathway, for preventing lipid peroxidation in vitro. It is noteworthy that HO modulation in vivo was also associated with plasma LPO levels without affecting plasma lipid profiles ( Figure 5 ). This result indicates that antiatherogenic properties of HO-1 may be explained, in part, by the suppression of lipid peroxidation. Previous studies have shown that feedings of L-arginine, the substrate of nitric oxide synthase (NOS), 47 or the transfer of the neural NOS gene 48 decreased atherosclerotic lesion formation in LDL-receptor knockout mice and cholesterolfed rabbits, although plasma NOx levels were not measured in these studies. In this respect, we were interested in the possible involvement of the NO pathway after high-fat diet trials. Plasma NOx levels are a stable end product of NO. 49 Because NO metabolism is influenced by endogenous nonenzymatic reactions 43 and exogenous factors, such as food and gastrointestinal microorganisms, 44 we placed animals in an air-filtered clean room, strictly monitored them for microorganisms, and fed them diets with identical composition of carbohydrates, proteins, and L-arginine. As shown in Figure  6A , plasma NOx levels were decreased after high-fat diets. Interestingly, HO-1 modulation was inversely associated with plasma NOx levels, although the precise mechanism is not evident at present. These results indicate that other antiatherogenic properties of HO under hypercholesteremia may be conducted through the influences on the NO pathway, although direct action of hemin, desferrioxamine, and SnPP IX on the NOS signaling pathway need to be investigated additionally. 50 In conclusion, our data indicate the possibility that HO-1 contributes to the balance of prooxidant and antioxidant elements in vivo as well as in vitro. These results are consistent with the oxidative hypothesis for atherosclerosis. 26 -29 In this study, we could not determine which product of HO-1 reaction is dominantly responsible against atherogenesis and lipid peroxidation. Additional investigation directly modulating biliverdin/bilirubin, CO, or iron/ferritin will be important to understand the function of HO-1. We are also pursuing experiments using HO-1 knockout mice to additionally examine the effect of HO-1 on atherogenesis, because nonselective effects of metalloporphyrins other than HO have been reported recently. 50 However, such nonselective effects of the reagents may not explain all of the observed data in this study, because hemin, which induces HO-1 without modulating other enzymes, such as NOS, had antiatherogenic effects. Unfortunately, homozygous HO-1 knockout mice breed extremely poorly, especially when maintained on C57BL/6J, apolipoprotein E, or LDL-receptor knockout backgrounds. Recent studies revealed that HO-1 is also induced in various cardiovascular disorders, such as pressure or volume overload of the heart, 51 hypertension, 25 subarachnoidal hemorrhage, 52 neointima formation after balloon injury, 53 and heart transplantation. 54 Thus, an understanding of the mechanisms by which HO-1 prevents various oxidative stresses may well be important for the treatment of a variety of pathophysiological conditions, including atherogenesis.
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